- Home
- BCML vs AVIR Comparison
BCML vs AVIR Comparison
Compare BCML & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- AVIR
- Stock Information
- Founded
- BCML 2004
- AVIR 2012
- Country
- BCML United States
- AVIR United States
- Employees
- BCML N/A
- AVIR N/A
- Industry
- BCML Major Banks
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- BCML Finance
- AVIR Health Care
- Exchange
- BCML Nasdaq
- AVIR Nasdaq
- Market Cap
- BCML 279.0M
- AVIR 273.7M
- IPO Year
- BCML N/A
- AVIR 2020
- Fundamental
- Price
- BCML $25.98
- AVIR $2.97
- Analyst Decision
- BCML
- AVIR Hold
- Analyst Count
- BCML 0
- AVIR 1
- Target Price
- BCML N/A
- AVIR $6.00
- AVG Volume (30 Days)
- BCML 29.1K
- AVIR 381.8K
- Earning Date
- BCML 04-17-2025
- AVIR 05-13-2025
- Dividend Yield
- BCML 2.31%
- AVIR N/A
- EPS Growth
- BCML N/A
- AVIR N/A
- EPS
- BCML 2.10
- AVIR N/A
- Revenue
- BCML $95,714,000.00
- AVIR N/A
- Revenue This Year
- BCML $3.69
- AVIR N/A
- Revenue Next Year
- BCML $6.03
- AVIR N/A
- P/E Ratio
- BCML $12.38
- AVIR N/A
- Revenue Growth
- BCML N/A
- AVIR N/A
- 52 Week Low
- BCML $18.54
- AVIR $2.60
- 52 Week High
- BCML $30.13
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- BCML 54.00
- AVIR 51.96
- Support Level
- BCML $24.17
- AVIR $2.77
- Resistance Level
- BCML $26.25
- AVIR $2.98
- Average True Range (ATR)
- BCML 1.46
- AVIR 0.21
- MACD
- BCML 0.19
- AVIR 0.02
- Stochastic Oscillator
- BCML 78.66
- AVIR 64.91
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).